Royalty Report: Medical, Device, Radiation – Collection: 121934

$100.00

Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 3

Primary Industries

  • Medical
  • Device
  • Radiation
  • Therapeutic
  • X-ray

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 121934

License Grant
German Licensor hereby grants to Licensee a worldwide, non-exclusive license under the Licensed Technology, including a sublicense under the Hehrlein license, to practice methods and to design, develop, manufacture, have manufactured, import, export, use, offer to sell, sell and otherwise dispose of License Products in the Field.

Sublicensees. Licensee shall give Licensor notice of any sublicense granted by Licensee. Licensee shall be responsible for all obligations of such sublicensees hereunder, including without limitation their obligation to maintain confidentiality of information and to report Net Sales and to pay royalties on sales of Licensed Products.

License Property
Licensor has developed and owns certain proprietary processes and materials from the manufacture of medical devices for the delivery of radiation therapy to the human body.  Licensor is the exclusive licensee of the Hehrlein Patents (as defined below);

Licensee desires to acquire a license to such technology and a sublicense to such patents for the development, manufacture and commercialization of medical devices for the delivery of radiation therapy to the human body; and Licensor is willing to grant such license and sublicense upon the terms and subject to the conditions set forth herein.

'Hehrlein Patents' shall mean all patents, pending patent applications and improvements related to be 'C. Hehrlein Balloon-Based Radiation Delivery Devices' as more fully described on Exhibit A.

EXHIBIT A –  LICENSED PATENTS
German Patent # DE 19600669 C2
PCT Application # WO 96/22121 41

All other issued patents and patent applications licensed to Licensor dealing with 'C. Hehrlein Balloon-Based Radiation Delivery Devices'

Field of Use
'Field' shall mean the design, development and commercialization of medical devices suitable for the radioactive treatment of occlusive cardiovascular and peripheral vascular diseases.

IPSCIO Record ID: 215206

License Grant
Licensor grants a worldwide right and license to manufacture and sell X-Ray Systems exclusively to Licensor for use in the Field.

Licensor grants a worldwide, non-exclusive license to manufacture, use and sell Delivery Devices outside the Field.

Pursuant to this agreement, each party will have the licensed rights to use the X-Ray System or components.  The parties have agreed to develop certain X-Ray Systems which incorporate and combine Catheter Body Subassemblies and Delivery Devices developed and manufactured by Licensee with X-Ray Tubes and Control Devices developed and manufactured by Licensor.

License Property
The Parties will co-develop and co-manufacture a disposable miniature x-ray source, based on the X-SEED and associated technology, for the delivery of intravascular radiation therapy to prevent restenosis (re-narrowing) of coronary arteries following angioplasty and stent procedures.  The new system will include an integrated disposable x-ray tube and catheter and a delivery and control device to deliver intravascular radiation therapy. Both companies will manufacture components for the system, which will be co-labeled.

Pursuant to this agreement, each party will have the licensed rights to use the X-Ray System or components.  The parties have agreed to develop certain X-Ray Systems which incorporate and combine Catheter Body Subassemblies and Delivery Devices developed and manufactured by Licensee with X-Ray Tubes and Control Devices developed and manufactured by Licensor.

X-Seed is a prototype of a new system for delivering x-rays from inside blood vessels following an operation for clogged arteries.

Based on a concept of the Licensor's patented and patent-pending technology, the x-ray source uses a combination of lasers, fiber optics and high voltages to produce x-rays. The X-Seed miniature x-ray system is completely self-contained, and its key components are less than one millimeter in diameter. X-Seed is designed to be placed at the end of a fine, flexible catheter, which will then be inserted inside blood vessels to deliver a dose of radiation to the interior surface.

The overall components of the system are:  Catheter Body Subassembly,  X-Ray Tube, Control Device and Delivery Device.

Field of Use
The Field shall mean the field of Intravascular Radiotherapy.

Intravascular Radiotherapy is a radiation therapy system that helps prevent the repeated narrowing of coronary arteries that have already undergone the procedure of stenting.

Licensee is leveraging its core expertise in miniature x-ray technology into distinct markets including cancer treatment, intravascular care, industrial x-ray, and radiation dosimetry products.

IPSCIO Record ID: 204314

License Grant
Licensor grants a worldwide, exclusive license to use and sell X-Ray Systems in the Field.  Licensee desires to be the exclusive marketing and distribution entity for X-Ray Systems.
License Property
The Parties will co-develop and co-manufacture a disposable miniature x-ray source, based on the X-SEED and associated technology, for the delivery of intravascular radiation therapy to prevent restenosis (re-narrowing) of coronary arteries following angioplasty and stent procedures.  The new system will include an integrated disposable x-ray tube and catheter and a delivery and control device to deliver intravascular radiation therapy. Both companies will manufacture components for the system, which will be co-labeled.

Pursuant to this agreement, each party will have the licensed rights to use the X-Ray System or components.  The parties have agreed to develop certain X-Ray Systems which incorporate and combine Catheter Body Subassemblies and Delivery Devices developed and manufactured by Licensee with X-Ray Tubes and Control Devices developed and manufactured by Licensor.

X-Seed is a prototype of a new system for delivering x-rays from inside blood vessels following an operation for clogged arteries.

Based on a concept of the Licensor's patented and patent-pending technology, the x-ray source uses a combination of lasers, fiber optics and high voltages to produce x-rays. The X-Seed miniature x-ray system is completely self-contained, and its key components are less than one millimeter in diameter. X-Seed is designed to be placed at the end of a fine, flexible catheter, which will then be inserted inside blood vessels to deliver a dose of radiation to the interior surface.

The overall components of the system are:  Catheter Body Subassembly,  X-Ray Tube, Control Device and Delivery Device.

Field of Use
The Field shall mean the field of Intravascular Radiotherapy.

Intravascular Radiotherapy is a radiation therapy system that helps prevent the repeated narrowing of coronary arteries that have already undergone the procedure of stenting.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.